50:
1037:
280:
234:
219:
284:
914:
137:"Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy"
249:
394:
835:
545:
498:
399:
323:
694:
404:
1078:
96:"An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients"
471:
980:
830:
555:
316:
820:
731:
560:
904:
295:
672:
533:
431:
1012:
947:
483:
409:
1071:
997:
778:
714:
662:
650:
421:
389:
309:
1097:
909:
724:
676:
615:
336:
800:
766:
466:
260:
179:
63:
1102:
493:
1064:
970:
756:
640:
605:
523:
456:
379:
1007:
136:
929:
919:
825:
49:
17:
238:
175:
874:
788:
924:
879:
158:
117:
38:
1048:
301:
148:
107:
985:
254:
243:
1091:
580:
512:
895:
884:
265:
1036:
864:
350:
195:
67:
228:
153:
135:
Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M (October 1997).
368:
112:
95:
121:
162:
1044:
853:
594:
445:
43:
211:
703:
629:
332:
810:
359:
344:
223:
289:
745:
74:
305:
94:
Palmieri S, D'Arco AM, Celentano M, et al. (July 2006).
915:
Adult type of generalized eruption of cutaneous mastocytosis
198:
entry in the public domain NCI Dictionary of Cancer Terms
1052:
201:
994:
967:
960:
938:
893:
861:
852:
797:
775:
753:
744:
711:
702:
693:
659:
637:
628:
602:
593:
573:
542:
520:
511:
480:
453:
444:
418:
376:
367:
358:
343:
205:
37:
32:
77:, "Smoldering leukemia" is classified under RAEB.
836:Refractory cytopenia with multilineage dysplasia
499:Accelerated phase chronic myelogenous leukemia
1072:
317:
8:
1079:
1065:
964:
858:
750:
708:
699:
634:
599:
517:
450:
373:
364:
355:
324:
310:
302:
202:
48:
29:
178:at the U.S. National Library of Medicine
152:
111:
816:Refractory anemia with excess of blasts
86:
60:Refractory anemia with excess of blasts
33:Refractory anemia with excess of blasts
7:
1033:
1031:
981:Acute panmyelosis with myelofibrosis
831:Paroxysmal nocturnal haemoglobinuria
18:Refractory anemia with excess blasts
1051:. You can help Knowledge (XXG) by
25:
1035:
556:Juvenile myelomonocytic leukemia
283: This article incorporates
278:
821:Chromosome 5q deletion syndrome
732:Acute megakaryoblastic leukemia
561:Chronic myelomonocytic leukemia
472:Myeloid dendritic cell leukemia
70:blast percentage of 5% to 19%.
905:Diffuse cutaneous mastocytosis
296:U.S. National Cancer Institute
1:
673:Chronic eosinophilic leukemia
432:Chronic neutrophilic leukemia
1013:Biphenotypic acute leukaemia
948:Xanthelasmoidal mastocytosis
390:Acute myeloblastic leukemia
1119:
1030:
910:Erythrodermic mastocytosis
725:Essential thrombocythaemia
677:Hypereosinophilic syndrome
291:Dictionary of Cancer Terms
337:haematological malignancy
180:Medical Subject Headings
154:10.1182/blood.V90.8.2969
64:myelodysplastic syndrome
494:Philadelphia chromosome
285:public domain material
1008:Primary myelofibrosis
940:Systemic mastocytosis
885:Systemic mastocytosis
113:10.1093/annonc/mdl083
930:Solitary mastocytoma
920:Urticaria pigmentosa
826:Sideroblastic anemia
176:Leukemia,+Smoldering
62:(RAEB) is a type of
196:Smoldering leukemia
875:Mast cell leukemia
789:Polycythaemia vera
767:Erythroleukemia/M6
651:Acute eosinophilic
1098:Myeloid neoplasia
1060:
1059:
1025:
1024:
1021:
1020:
956:
955:
925:Mast cell sarcoma
880:Mast cell sarcoma
848:
847:
844:
843:
811:Refractory anemia
740:
739:
689:
688:
685:
684:
624:
623:
589:
588:
569:
568:
507:
506:
440:
439:
275:
274:
57:
56:
27:Medical condition
16:(Redirected from
1110:
1081:
1074:
1067:
1039:
1032:
1001:
974:
965:
961:Multiple/unknown
941:
898:
868:
859:
804:
782:
760:
751:
718:
709:
700:
666:
644:
635:
616:Acute basophilic
609:
600:
549:
527:
518:
487:
460:
451:
425:
383:
374:
365:
356:
326:
319:
312:
303:
299:
282:
281:
203:
183:
173:
167:
166:
156:
132:
126:
125:
115:
91:
53:
52:
30:
21:
1118:
1117:
1113:
1112:
1111:
1109:
1108:
1107:
1088:
1087:
1086:
1085:
1028:
1026:
1017:
995:
990:
986:Myeloid sarcoma
968:
952:
939:
934:
894:
889:
862:
840:
798:
793:
776:
771:
754:
736:
712:
681:
660:
655:
638:
620:
603:
585:
565:
543:
538:
521:
503:
481:
476:
454:
436:
419:
414:
377:
348:
339:
330:
288:
279:
276:
271:
270:
214:
192:
187:
186:
174:
170:
134:
133:
129:
93:
92:
88:
83:
47:
28:
23:
22:
15:
12:
11:
5:
1116:
1114:
1106:
1105:
1103:Oncology stubs
1100:
1090:
1089:
1084:
1083:
1076:
1069:
1061:
1058:
1057:
1040:
1023:
1022:
1019:
1018:
1016:
1015:
1010:
1004:
1002:
992:
991:
989:
988:
983:
977:
975:
962:
958:
957:
954:
953:
951:
950:
944:
942:
936:
935:
933:
932:
927:
922:
917:
912:
907:
901:
899:
891:
890:
888:
887:
882:
877:
871:
869:
856:
850:
849:
846:
845:
842:
841:
839:
838:
833:
828:
823:
818:
813:
807:
805:
795:
794:
792:
791:
785:
783:
773:
772:
770:
769:
763:
761:
748:
742:
741:
738:
737:
735:
734:
728:
727:
721:
719:
706:
697:
691:
690:
687:
686:
683:
682:
680:
679:
669:
667:
657:
656:
654:
653:
647:
645:
632:
626:
625:
622:
621:
619:
618:
612:
610:
597:
591:
590:
587:
586:
584:
583:
577:
575:
571:
570:
567:
566:
564:
563:
558:
552:
550:
540:
539:
537:
536:
530:
528:
515:
509:
508:
505:
504:
502:
501:
496:
490:
488:
478:
477:
475:
474:
469:
463:
461:
448:
442:
441:
438:
437:
435:
434:
428:
426:
416:
415:
413:
412:
407:
402:
397:
392:
386:
384:
371:
362:
353:
341:
340:
331:
329:
328:
321:
314:
306:
273:
272:
269:
268:
257:
246:
231:
215:
210:
209:
207:
206:Classification
200:
199:
191:
190:External links
188:
185:
184:
168:
147:(8): 2969–77.
127:
106:(7): 1146–51.
85:
84:
82:
79:
55:
54:
41:
35:
34:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1115:
1104:
1101:
1099:
1096:
1095:
1093:
1082:
1077:
1075:
1070:
1068:
1063:
1062:
1056:
1054:
1050:
1047:article is a
1046:
1041:
1038:
1034:
1029:
1014:
1011:
1009:
1006:
1005:
1003:
1000:
999:
993:
987:
984:
982:
979:
978:
976:
973:
972:
966:
963:
959:
949:
946:
945:
943:
937:
931:
928:
926:
923:
921:
918:
916:
913:
911:
908:
906:
903:
902:
900:
897:
892:
886:
883:
881:
878:
876:
873:
872:
870:
867:
866:
860:
857:
855:
851:
837:
834:
832:
829:
827:
824:
822:
819:
817:
814:
812:
809:
808:
806:
803:
802:
796:
790:
787:
786:
784:
781:
780:
774:
768:
765:
764:
762:
759:
758:
752:
749:
747:
743:
733:
730:
729:
726:
723:
722:
720:
717:
716:
710:
707:
705:
701:
698:
696:
692:
678:
674:
671:
670:
668:
665:
664:
658:
652:
649:
648:
646:
643:
642:
636:
633:
631:
627:
617:
614:
613:
611:
608:
607:
601:
598:
596:
592:
582:
581:Histiocytosis
579:
578:
576:
572:
562:
559:
557:
554:
553:
551:
548:
547:
541:
535:
532:
531:
529:
526:
525:
519:
516:
514:
513:Myelomonocyte
510:
500:
497:
495:
492:
491:
489:
486:
485:
479:
473:
470:
468:
465:
464:
462:
459:
458:
452:
449:
447:
443:
433:
430:
429:
427:
424:
423:
417:
411:
408:
406:
403:
401:
398:
396:
393:
391:
388:
387:
385:
382:
381:
375:
372:
370:
366:
363:
361:
357:
354:
352:
346:
342:
338:
334:
327:
322:
320:
315:
313:
308:
307:
304:
300:
297:
293:
292:
286:
267:
263:
262:
258:
256:
252:
251:
247:
245:
241:
240:
236:
232:
230:
226:
225:
221:
217:
216:
213:
208:
204:
197:
194:
193:
189:
181:
177:
172:
169:
164:
160:
155:
150:
146:
142:
138:
131:
128:
123:
119:
114:
109:
105:
101:
97:
90:
87:
80:
78:
76:
71:
69:
65:
61:
51:
45:
42:
40:
36:
31:
19:
1053:expanding it
1042:
1027:
996:
969:
896:Mastocytosis
863:
815:
799:
777:
755:
713:
661:
639:
604:
544:
522:
482:
455:
420:
378:
351:granulocytes
290:
277:
259:
248:
233:
218:
171:
144:
140:
130:
103:
99:
89:
72:
59:
58:
865:Mastocytoma
1092:Categories
349:and other
100:Ann. Oncol
81:References
369:Myelocyte
335:-related
39:Specialty
1045:oncology
854:CFU-Mast
595:CFU-Baso
446:Monocyte
122:16687417
44:Oncology
704:CFU-Meg
630:CFU-Eos
467:AMoL/M5
333:Myeloid
266:D000754
255:M9983/3
163:9376577
66:with a
410:APL/M3
360:CFU-GM
345:CFU-GM
244:238.73
182:(MeSH)
161:
120:
68:marrow
46:
1043:This
746:CFU-E
574:Other
546:MD-MP
287:from
250:ICD-O
229:D46.2
141:Blood
1049:stub
261:MeSH
239:9-CM
159:PMID
118:PMID
75:MeSH
971:AML
757:AML
695:MEP
641:AML
606:AML
524:AML
484:CML
457:AML
380:AML
235:ICD
220:ICD
149:doi
108:doi
73:In
1094::
998:MP
801:MD
779:MP
715:MP
663:MP
534:M4
422:MP
405:M2
400:M1
395:M0
294:.
264::
253::
242::
227::
224:10
157:.
145:90
143:.
139:.
116:.
104:17
102:.
98:.
1080:e
1073:t
1066:v
1055:.
675:/
347:/
325:e
318:t
311:v
298:.
237:-
222:-
212:D
165:.
151::
124:.
110::
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
